Paris Saponin II-induced Paraptosis-Associated Cell Death Increased the Sensitivity of Cisplatin.

Shuli Man,Panpan Lv,Jingxia Cui,Furui Liu,Lei Peng,Long Ma,Changxiao Liu,Wenyuan Gao
DOI: https://doi.org/10.1016/j.taap.2020.115206
IF: 4.46
2020-01-01
Toxicology and Applied Pharmacology
Abstract:Paris Saponin II (PSII) has been regarded as an effective and imperative component isolated from Rhizoma Paridis saponins (RPS) and exhibited strong anti-tumor effects on a variety of cancer. Our results revealed that human non-small lung cancer cell lines NCI-H460 and NCI-H520 were exposed to 1 μM of PSII, which inhibited the proliferation of lung cancer cells and activated apoptosis, autophagy and paraptosis. PSII induced paraptosis-associated cell death prior to apoptosis and autophagy. It induced paraptosis based on ER stress through activation of the JNK pathway. Meanwhile, PSII increased the cytotoxicity of cisplatin through paraptosis-associated pathway. All in all, PSII induced paraptosis based on induction of non-apoptotic cell death, which would be a possible approach to suppress the multi-drug resistant to apoptosis.
What problem does this paper attempt to address?